BAY-1214784

oral hGnRH-R hormone receptor antagonist

to treat of uterine fibroids, Ph. I completed

from cell-based 2.5M cmpd HTS + opt.

J. Med. Chem., Oct. 22, 2020 issue

Bayer AG, Berlin, DE

October’s molecule, the Bayer hGnRH-R antagonist BAY 1214784, is intended as an oral, once-daily treatment for uterine fibroids, a highly common problem in adult women that can lead to infertility. Existing…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks